Author:
Inoue Kazuhiro,Kumazawa Eiji,Kuga Hiroshi,Susaki Hiroshi,Masubuchi Noriko,Kajimura Tetsuyo
Reference16 articles.
1. Ringsdorf, H., 1975, Structure and properties of pharmacologically active polymers. J. Polym. Sci. Polym. Symp. 20: 135–153.
2. Matsumura, Y., and Maeda, H., 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism and antitumor agent smancs. Cancer Res. 46: 6387–6392.
3. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K., 2000, Tumor vascular permeability and EPR effect in macromolecular therapeutics: a review. J. Control. Release 65: 271–284.
4. Maeda, H., 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advan. Enzyme Regul. 41: 189–207.
5. Duncan, R., Seymour, L.W., O’Hare, K.B., Flanagan, P.A., Wedge, S., Hume, I.C., Ulbrich, K., Strohalm, J., Subr, V., Spareafico, F., Grandi, M., Ripamonti, M., Farao, M., and Suarato, A., 1992, Preclinical evaluation of polymer-bound doxorubicin. J. Control. Release 19: 331–346.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献